From moral failing to medical condition: How Illinois redefined addiction treatment
- jameliahand
- Jun 3
- 4 min read
Updated: Jun 6
By Jamelia Hand MHS CADC CODP I
Dr. Bearden believed recovery should begin where patients already felt safe, his practice was their front door.
In 2007, I had the honor of consulting with Dr. Bearden, a dedicated physician whose private practice in Illinois served as both a primary care home and a place of healing for individuals living with opioid use disorder. Long before it was common, Dr. Bearden provided office-based opioid treatment (OBOT), offering buprenorphine in a setting that respected his patients’ dignity.
We often talked about how far the field had come. He had worked in treatment programs for decades and witnessed firsthand the shift from control-based care to something more humane. “When I first started,” he once told me, “you didn’t say you were helping people with addiction. That wasn’t something to be proud of back then. But I always knew we could do better.”
Dr. Bearden didn’t just believe in treatment, he believed in access. Our collaboration focused on expanding his capacity to serve more patients while staying compliant with state requirements. I worked alongside his team to strengthen documentation practices, align workflows with regulatory standards, and position his office as both compliant and compassionate.
He passed away, but I still think of him often. If he were here today, I believe he’d be incredibly proud of what Illinois has accomplished, and still passionately invested in the work ahead.
A Look Back:
The 1975 Illinois Dangerous Drugs Commission Rules
The Illinois Dangerous Drugs Commission (IDDC), established under the 1967 Dangerous Drug Abuse Act, served as the state’s regulatory authority during a time when substance use was viewed primarily through a lens of criminality and moral failure. By 1975, its licensure rules reflected a restrictive and punitive approach.
Facilities operated under intense surveillance and administrative control, emphasizing abstinence and compliance over individualized care. Detox and methadone clinics were treated with skepticism, and community providers were limited in both scope and flexibility. Treatment programs were rarely trauma-informed, and the notion of harm reduction was virtually non-existent.
Even documentation requirements reflected this mindset: the emphasis was on controlling diversion and tracking patient “misbehavior,” not healing.
The Revised Illinois Administrative Code Part 2060: A Framework for Patient Centered Care
The modern standard for substance use disorder treatment in Illinois is found in Title 77, Part 2060 of the Illinois Administrative Code. It represents a transformation from the control-focused era of the 1970s to a science-informed, patient-centered, and rights-based approach to care.
Key Improvements Include:
1. A Continuum of Care
Providers are now licensed to offer a spectrum of services, from early intervention to intensive outpatient and residential treatment based on ASAM placement criteria, allowing for individualized care based on severity and readiness.
2. Competent, Credentialed Workforce
Unlike in 1975, today’s staff must meet professional credentialing and ongoing training requirements in ethics, trauma, and cultural responsiveness.
3. Patient Rights and Participation
Patients are no longer passive recipients of care. They must be involved in treatment planning, informed of their rights, and given the autonomy to make decisions about their care. Confidentiality laws are firmly embedded in policy.
4. Inclusion of Medication-Assisted Treatment (MAT)
Part 2060 legitimizes and supports the use of FDA-approved medications like buprenorphine and methadone. OBOTs like Dr. Bearden’s are now an essential part of the treatment ecosystem.
5. Modernization Efforts
Recent revisions focus on reducing unnecessary paperwork, eliminating stigmatizing language, and improving operational efficiency, all while maintaining safety and care standards.
What’s Changed, and Enhancements Yet to be Made:
• Access: More providers are offering OBOT, expanding care beyond traditional treatment centers.
• Language: Terms like “abuse” and “addict” have been replaced with respectful, person-first language.
• Integration: SUD treatment is increasingly woven into healthcare, criminal justice, and social services systems.
Persistent Gaps:
• Workforce Shortage: Recruiting and retaining qualified staff remains a major challenge, particularly in rural areas.
• Peer Integration: Regulations have yet to fully reflect the growing and essential role of peer support specialists.
• Disparities in Reimbursement: Office-based practices still face hurdles in billing and payment, creating a disincentive to expand MAT services.
• Outcome Measures: We need better mechanisms to track what matters including long-term recovery, social connectedness, and health equity.
Why This Matters
Providers like Dr. Bearden were ahead of their time. He treated opioid use disorder with the same urgency and care as diabetes or hypertension. I was fortunate to help him bring his vision to life, not just by translating policy into practice, but by making compliance a tool for expanding impact, not a barrier to care.
We’ve come a long way from 1975, but honoring pioneers like him means continuing the push forward, making sure our systems of care evolve, and that access is never based on privilege.
How Vantage Can Help
At Vantage Clinical Consulting, we work alongside private practice physicians, opioid treatment providers, and health systems to align operations with regulations while keeping care humane. Whether you’re launching a new OBOT program, expanding services, or preparing for licensure, we support you in building compliant, scalable, and patient-first programs.
We turn regulatory complexity into practical strategies, and we do it with the compassion and leadership Dr. Bearden would have expected.
Comments